NCT04352725

Brief Summary

Mechanical ventilation of the patient with acute respiratory distress syndrome is one of the first therapies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 20, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
Last Updated

April 20, 2020

Status Verified

April 1, 2020

Enrollment Period

11 months

First QC Date

April 16, 2020

Last Update Submit

April 16, 2020

Conditions

Keywords

respiratory distresstitrationend-expiratory

Outcome Measures

Primary Outcomes (1)

  • Observe end-expiratory lung volume change during an increasing PEEP titration procedure in patients with moderate to severe ARDS

    1 day

Secondary Outcomes (6)

  • Define a threshold of end-expiratory lung volume variation to help determine optimal PEEP

    1 day

  • Analyzing the effect of PEEP titration on static compliance and dynamic strain

    1 day

  • Effect of PEEP titration on hematosis via the calculation of the Pao2/Fio2 ratio for each PEEP step thanks to the measurement of Pao2 on arterial gasometry

    1 day

  • Study the correlation between % change in end-expiratory lung volume and improvement in hematosis (Pao2/Fio2)

    1 day

  • Compare end-expiratory lung volume variations according to the type of ARDS (severity, focal or diffuse, pulmonary or extra-pulmonary etiology)

    1 day

  • +1 more secondary outcomes

Study Arms (1)

experimental procedure

EXPERIMENTAL

* end-expiratory lung volume measurement procedure according to the PEEP level set by the clinician, respecting a Vt at 6ml/kg IBW and Pplat\<28cmH2o * incremental PEEP titration procedure in 5 steps starting from 5cmH2o up to 20cmH2o

Procedure: End-expiratory lung volume measurement and incremental PEEP titration

Interventions

* End expiratory lung volume measurement procedure according to the PEEP level set by the clinician, respecting a Vt at 6ml/kg IBW and Pplat\<28cmH2o * incremental PEEP titration procedure in 5 steps starting from 5cmH2o up to 20cmH2o

experimental procedure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to intensive care with a diagnosis of moderate to severe ARDS in accordance with the Berlin criteria, i.e. a PAFI \<200 and PEEP \>5cm H20 ratio
  • Diagnosis of ARDS made within 72 hours
  • Age over 18 years
  • Informed consent of the patient and/or trusted person where applicable

You may not qualify if:

  • SDRA evolving for more than 72 hours
  • Presence of major hemodynamic instability with mean blood pressure \<60mmhg, and/or heart rate \<45 bpm or \>150bpm with an increase in vasopressor amine dosage of more than 20% over the last 6 hours.
  • Intracranial hypertension with CPP\<60mmhg
  • Massive hemoptysis requiring immediate surgical or interventional radiology procedure
  • Tracheal surgery (except intensive care tracheotomy) or sternotomy within the previous 15 days
  • Trauma or surgery of the face in the previous 15 days.
  • Deep vein thrombosis treated for less than 2 days
  • Pacemaker implantation in the last 2 days
  • Unstable fracture (spine, femur or pelvis)
  • Respiratory reasons
  • use of extracorporeal oxygenation
  • nitric oxide
  • pleural drainage system with bronchopleural gap
  • pulmonary transplantation
  • Poor respiratory tolerance per procedure with desaturation Spo2\<85%.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Intercommunal Aix-Pertuis

Aix-en-Provence, 13100, France

RECRUITING

Related Publications (5)

  • Casserly B, McCool FD, Saunders J, Selvakumar N, Levy MM. End-Expiratory Volume and Oxygenation: Targeting PEEP in ARDS Patients. Lung. 2016 Feb;194(1):35-41. doi: 10.1007/s00408-015-9823-6. Epub 2015 Dec 8.

    PMID: 26645226BACKGROUND
  • Maggiore SM, Jonson B, Richard JC, Jaber S, Lemaire F, Brochard L. Alveolar derecruitment at decremental positive end-expiratory pressure levels in acute lung injury: comparison with the lower inflection point, oxygenation, and compliance. Am J Respir Crit Care Med. 2001 Sep 1;164(5):795-801. doi: 10.1164/ajrccm.164.5.2006071.

    PMID: 11549535BACKGROUND
  • Olegard C, Sondergaard S, Houltz E, Lundin S, Stenqvist O. Estimation of functional residual capacity at the bedside using standard monitoring equipment: a modified nitrogen washout/washin technique requiring a small change of the inspired oxygen fraction. Anesth Analg. 2005 Jul;101(1):206-12, table of contents. doi: 10.1213/01.ANE.0000165823.90368.55.

    PMID: 15976233BACKGROUND
  • Sahetya SK, Goligher EC, Brower RG. Fifty Years of Research in ARDS. Setting Positive End-Expiratory Pressure in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2017 Jun 1;195(11):1429-1438. doi: 10.1164/rccm.201610-2035CI.

    PMID: 28146639BACKGROUND
  • Dellamonica J, Lerolle N, Sargentini C, Beduneau G, Di Marco F, Mercat A, Richard JC, Diehl JL, Mancebo J, Rouby JJ, Lu Q, Bernardin G, Brochard L. PEEP-induced changes in lung volume in acute respiratory distress syndrome. Two methods to estimate alveolar recruitment. Intensive Care Med. 2011 Oct;37(10):1595-604. doi: 10.1007/s00134-011-2333-y. Epub 2011 Aug 25.

    PMID: 21866369BACKGROUND

MeSH Terms

Conditions

Respiratory Distress SyndromeDyspnea

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Laurent LEFEBVRE, Dr.

    Centre Hospitalier Intercommunal Aix-Pertuis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agathe BOULANT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor, rescuer

Study Record Dates

First Submitted

April 16, 2020

First Posted

April 20, 2020

Study Start

January 20, 2020

Primary Completion

November 30, 2020

Study Completion

November 30, 2020

Last Updated

April 20, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations